SANUWAVE, Inc. is an emerging leader in the development and commercialization of noninvasive, biological response activating devices in the regenerative medicine area for the repair and regeneration of tissue, musculoskeletal and vascular structures. SANUWAVE s portfolio of products and product candidates activate biologic signaling and angiogenic responses, including revascularization and microcirculatory improvement, helping restore the body s normal healing processes and regeneration. SANUWAVE is applying its Pulsed Acoustic Cellular Expression PACE technology in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions.
Quote | Sanuwave Health Inc (OTCMKTS:SNWV)
Last: | $0.018 |
---|---|
Change Percent: | 3.15% |
Open: | $0.017 |
Close: | $0.01745 |
High: | $0.018 |
Low: | $0.017 |
Volume: | 494,165 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | Sanuwave Health Inc (OTCMKTS:SNWV)
SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared to Q2 2023. UltraMist revenues for Q2 2024...
Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - ( NewMediaWire ) - June 26, 2024 - SANUWAVE Health, Inc. (the “Company”...
Message Board Posts | Sanuwave Health Inc (OTCMKTS:SNWV)
Subject | By | Source | When |
---|---|---|---|
Three debt overhang is killing this stock | janeyH | investorshub | 04/28/2023 3:27:29 AM |
One of my rays of hope here was | janeyH | investorshub | 04/28/2023 3:25:51 AM |
What an Effin Joke Morgan Frank and Kevin Richardson | kellyemmerson | investorshub | 04/27/2023 7:50:53 PM |
0.018 this am | janeyH | investorshub | 04/27/2023 2:07:00 PM |
Continuing to be shit on | janeyH | investorshub | 04/27/2023 2:06:47 PM |
News, Short Squeeze, Breakout and More Instantly...
SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared to Q2 2023. UltraMist revenues for Q2 2024...
Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - ( NewMediaWire ) - June 26, 2024 - SANUWAVE Health, Inc. (the “Company”...
SANUWAVE pays off $6.3 million Celularity note and interest for $2.075 million SEPA merger outside date to be extended to June 30, 2024 Combined entity has applied to list on Cboe BZX Exchange, Inc. EDEN PRAIRIE, MN - ( NewMediaWire ) - June 04, 2024 - SANUWAVE...